Policies for use of real-world data in health technology assessment: a comparative study of six HTA agencies

Value in Health

11 April 2017 - Health technology assessment agencies worldwide are thus exploring whether real-world data may provide alternative sources of data on effectiveness of interventions. 

Presently, an overview of health technology assessment (HTA) agencies’ policies for real-world data (RWD) use in relative effectiveness assessments (REA) is lacking.

 A literature review and stakeholder interviews were conducted to collect information on RWD policies for six HTA agencies: the Dental and Pharmaceutical Benefits Agency (Sweden), the National Institute for Health and Care Excellence (United Kingdom), the Institute for Quality and Efficiency in Healthcare (Germany), the High Authority for Health (France), the Italian Medicines Agency (Italy), and the National Healthcare Institute (The Netherlands).

Read Value in Health article

Michael Wonder

Posted by:

Michael Wonder